Drug Type Antibody |
Synonyms- |
Target |
Action modulators |
Mechanism ACVR2A modulators(activin A receptor type 2A modulators), ACVR2B modulators(Activin receptor type-2B modulators) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Originator Organization |
Active Organization |
Inactive Organization- |
License Organization- |
Drug Highest PhasePreclinical |
First Approval Date- |
Regulation- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Obesity | Preclinical | Switzerland | 22 May 2024 |